Unexpectedly apparently South Korea agreed to release the Russian vaccine, Sputnik V locally.
The results revealed today explain South Korean biotechnology firm GL Rapha will produce more than 150 million doses of the coronavirus vaccine each year.
The production of the vaccine produced by the Gamaleya Research Institute of Epidemiology and Microbiology is expected to begin next month, aiming to be distributed globally.
The effectiveness of Sputnik V was in question for a long time before Russia claimed their vaccine was 92% effective compared to Pfizer which was only 90% effective against COVID-19 infection.
For the use of its population, Russia has increased production capacity. They also agreed to produce 500 million doses annually as supplies to foreign countries.
The Russian Direct Investment Fund (RDIF) responsible for vaccine development and vaccine marketing nationwide claimed that Sputnik V had received orders for 1.2 billion doses of the vaccine.
